The aim of this study was to develop a murine model of burn wound healing. A thermal burn was induced on the dorsal skin of mice using a preheated brass template. Burned tissue was debrided and overlaid with a skin graft harvested from the tail of a genetically similar donor mouse.
Trivial superficial wounds heal without complications by primary intention. Deep wounds, such as full thickness burns, heal by secondary intention and require surgical debridement and skin grafting. Successful integration of the donor graft into a recipient wound bed depends on timely recruitment of immune cells, robust angiogenic response and new extracellular matrix formation. The development of novel therapeutic agents, which target some key processes involved in wound healing, are hindered by the lack of reliable preclinical models with optimized objective assessment of wound closure. Here, we describe an inexpensive and reproducible model of experimental full thickness burn wound reconstructed with an allogeneic skin graft. The wound is induced on the dorsum surface of anaesthetized inbred wild type mice from the BALB/C and SKH1-Hrhr backgrounds. The burn is produced using a brass template measuring 10 mm in diameter, which is preheated to 80 °C and delivered at a constant pressure for 20 s. Burn eschar is excised 24 hours after the injury and replaced with a full thickness graft harvested from the tail of a genetically similar donor mouse. No specialized equipment is required for the procedure and surgical techniques are straightforward to follow. The method may be effortlessly implemented and reproduced in most research settings. Certain limitations are associated with the model. Due to technical difficulties, the harvest of thinner split thickness skin grafts is not possible. The surgical method we describe here allows for the reconstruction of burn wounds using full thickness skin grafts. It may be used to carry out preclinical therapeutic testing.
Surgical debridement and skin grafting are common clinical practices used in the management of chronic wounds1, burn wounds2, and acute wounds such as traumatic wounds3. Skin grafting refers to the surgical procedure, which involves the removal of healthy skin from one part of the body and transferring it to another. Donor grafts replace the lost tissue and provide a structural scaffold for cellular migration and growth. Following integration into the recipient site, skin grafts replace the lost skin barrier by providing protection from microbial invasion, harmful effects of the external environment and excessive loss of moisture4. Successful skin graft integration depends on several factors. These include adequate immune responses in the presence of microbial infections and timely resolution of inflammation, robust angiogenesis at the wound site and establishment of vascular anastomoses between the recipient bed and the donor graft5. As the graft begins to degrade, resident dermal cells must be replaced by cells capable of producing new extracellular matrix. At the same time, the epidermal keratinocytes must crawl over the newly produced matrix to form the neo-epidermis and re-epithelialize the wound. It is, therefore, evident that efficient migration of cells from the recipient bed into the donor graft is another determining factor that influences successful graft incorporation. Given the vast number of factors involved in wound healing6, which may be impossible to control in the human trials due to ethical limitations, models of pre-clinical experimental skin grafting are necessary. Development of pre-clinical models of burn wound healing and associated skin grafting will be important for understanding of complex mechanisms involved in cutaneous tissue repair and essential for the testing of new therapeutic agents. The in vitro models of wound healing are unable to accurately mimic the complexity of the cutaneous tissue. The in vivo animal models are an indispensable investigative tool in understanding the mechanisms involved in tissue repair.
Several methods of skin grafting technique were developed in rodents to mimic surgical excision and burn wound reconstruction7,8,9. However, most of the previously described procedures failed to induce a thermal burn injury prior to skin grafting. Instead of the burn wound, a full thickness excisional wound was induced, which was then reconstructed with a full thickness skin allograft7. Various anatomical landmarks such as the ear, tail and back have been used for harvesting of the donor skin in rodents7,8. Different graft fixation and stabilization techniques were reported, including a “no suture technique”9, sutures7 and surgical glue10,11,12.
The purpose of this study was to develop a murine model of a full thickness burn wound that would recapitulate the current gold standard approach in burn treatment, which involves nonviable tissue excision and skin grafting. A thermal burn was induced on the dorsum surface of a mouse using a preheated brass template. Burn eschar was excised and replaced with a full thickness graft harvested from the tail of a donor mouse. There are three key advantages to this experimental model. First, more than one burn wound may be induced on the back of the recipient mouse, and four donor skin grafts may be harvested from a single tail of the donor mouse. This means that several experimental and control treatments may potentially be compared using the same recipient and donor animals. Depending on the desired route of administration, the control treatment may include local or systemic administration of the vehicle or placebo control (e.g., topical application of ointment, subcutaneous, intraperitoneal or intravenous injection of solution). Second, timing of the treatment and the endpoint of the experiment may be controlled. Third, this model depends on the reconstruction of wounds using full thickness grafts harvested from the tail, which are known to have a higher probability for successful incorporation into the donor site compared to the skin harvested from the back13. This may be due to the lower number of epidermal Langerhans cells, which play a key role in cutaneous immunobiology, and are associated with the skin graft rejection14.
The proposed model of wound healing and graft integration may well be applied to transgenic and knockout mice. The use of genetically modified mice will assist in elucidating the roles that certain genes may play during wound repair. Exogenous application of topical wound preparations or subcutaneous administration of therapeutic antibodies at the site of the injury may also be considered.
Due to technical difficulties, split thickness skin grafts consisting of the epidermis and part of the dermis are difficult to obtain in mice. Full thickness skin grafts consisting of the epidermis and full thickness dermis are known to require a well-vascularized wound bed for successful integration. The inability to harvest split thickness skin grafts in mice may be regarded as a limitation of this model. The fixation of the skin graft to the recipient wound bed was achieved via the application of the surgical adhesive glue, which is associated with less trauma and rapid degradation compared to other means of tissue fixation15. Previous studies have shown that suturing is associated with stronger tissue fixation than the surgical glue at 24 h after the surgical procedure15, which may be considered as a disadvantage of the procedure. However, at later timepoints, the biomechanical strength of wounds treated with a surgical adhesive becomes comparable to sutures15 and better than staple fixation16. Following tissue fixation with the surgical glue, wounds must be covered with a wound dressing. Although wounds on the dorsal surface of the mouse are difficult for the animal to reach, the wound dressing, on the other hand, is easy for the animal to manipulate and remove. Frequent wound dressing changes may be warranted.
Anesthesia-induced hypothermia in small rodents is a well-documented phenomenon17. Hypothermia is a side effect of this procedure, which causes complications, and potentially compromises both animal health and data quality. Therefore, this method warrants the implementation of temperature management strategies, especially if hairless SKH1-Hrhr are used.
The most significant limitation of using mice to mimic human wound closure is the difference between the skin anatomy and physiology. Mouse wounds heal mostly via contraction, whereas human wounds heal through granulation tissue formation and re-epithelialization18. To account for this discrepancy, the current model may be modified and used in combination with a splinting ring tightly adhered around the wound to prevent skin contraction19. Given some advantages and disadvantages of this in vivo protocol, this model could serve as a tool to study certain processes involved in wound healing that are impossible to study in vitro.
According to the thickness classification of burn injury23, full thickness burns are characterized by evident involvement of the whole thickness of the skin and certain portion of the subcutaneous tissue. This type of wound can heal only by contraction or with skin grafting2. An inherent limitation of the method described in this article is that only full thickness grafts, as opposed to the split thickness grafts, which are often used in the clinical setting, were harvested from the tail of a mouse. This was due to the technical difficulty, as the mouse skin is too thin to obtain split thickness grafts. It must be pointed out that full thickness grafts require a well vascularized wound bed, whereas split thickness skin grafts are able to survive at donor sites with less vascularity24. Previous studies showed that a burn wound induced on the back of the mouse was associated with a robust formation of new vasculature5. This suggests that a well vascularized area, such as the dorsum of the mouse, could be considered as the anatomical landmark for the induction of burn wounds.
Burn wound depth is an important factor to consider. The depth of the burn wound must be consistent between individual mice. The reproducibility of the burn wound depth depends on the temperature of the brass template, pressure and duration of the heat exposure. The burn wound depth must be verified histologically. It is important to keep in mind that excessive pressure or prolonged exposure of the skin to the preheated brass template may injure the underlying tissue. The tissue surrounding the vertebral column, including the components of the central and peripheral nervous system, are sensitive to heat, and if damaged may result in hind leg paralysis.
Although no postoperative mortality was directly associated with the surgical procedure, a small number of hairless SKH1-Hrhr mice, which are especially sensitive to cold, developed hypothermia and failed to recover after the general anaesthesia. Therefore, supplementary heat must be provided during all aesthetic events and constant surveillance is required while the mouse is anaesthetized.
The method described in this study was not associated with the surgical site infection. However, aseptic technique must be used to prevent the transfer of microorganisms into the surgical wound during the perioperative period. Inoculation of the wound with bioluminescent or fluorescent microorganisms may be incorporated into the procedure. This technique may be useful in studying infectious organisms and their pathogenesis25. For example, exogenous addition or injection of bioluminescent bacteria, may permit the monitoring of the microbial burden using the in vivo whole animal imaging25. Given that mouse hair is known to interfere with the in vivo whole animal fluorescence and bioluminescence imaging, hairless SKH1-Hrhr mice are ideal hosts for the studies involving fluorescent or bioluminescent reporters.
Wound tissue samples may be collected at different time points and processed for histological and immunohistochemical analysis. Protein and RNA may be isolated from the skin biopsy and molecular biology techniques may be used to assess the expression of key molecules involved in wound healing.
In the present study, we described an experimental model of burn wound healing and allogeneic skin engraftment. This procedure can be modified and serve as a model for preclinical studies.
The authors have nothing to disclose.
This work was supported by La Direction Générale de L'Armement, l’Agence de l’Innovation de Défense and École Polytechnique. We thank our colleague Mr Yann Plantier from École Polytechnique who provided insight and expertise that greatly assisted the production of the video file. The authors thank Mr Benoit Peuteman and Ms Charlotte Auriau from INSERM Lavoisier (SEIVIL) US 33, Hôpital Paul Brousse, Villejuif for their animal well-being and care expertise provided during the course of this project.
1 ml syringue | Terumo | SS + 01T1 | |
26 G needle | Terumo Agani | NN-2613R | 1/2'' – 0,45 X 12mm |
96X21 mm Petri Dish | Dutscher | 193199 | |
Animal Weighing scale | Kern | EMB 5.2K5 | |
BALB/c mouse | Janvier labs | BALB/cAnNRj | 6-weeks old |
Biopsy foam pads 30.2X25.4X2mm | Simport | M476-1 | |
Bond polymer Refine Red | Leica Biosystems | DS9390 | |
Brass block | BVG | custom-designed | Circular 10 mm in diameter |
Buprenorphine (BUPRECARE) | Axience | FR/V/6328396 3/2011 | administered subcutaneously at a dose of 0.05 μg/ g |
Burning apparatus Kausistar 400 | TraçaMatrix | 34010 | |
CaseViewer | 3DHISTECH Ltd. | 3Dhistech, Budapest, Hungary | |
Collagen I antibody | Abcam | ab34710 | Recommanded concentration 1:50; 1:200 |
D-(+)- glucose (Dextrose) | Sigma Aldrich | G-8769-100 ml | |
DAB | Leica Biosystems | AR9432 | |
Digital camera | NIKON | D3400 | objective: SIGMA 18-250mm F3.5-6.3 DC MACRO C45 |
Depilating cream | Veet | ||
Disposable scalpels | Swann Morton | 6601 | |
DPBS | PAN biotech | P04-36300 | |
Ethanol absolute | VWR chemicals | 20821.310 | |
Fibronectin antibody | Abcam | ab23750 | Recommanded dilution 1:1000 |
Filter 0.22um | Sartorius | 16532 | |
Fine Scissors | F.S.T. | 14094-11 | |
Forceps Dumont | F.S.T. | 11295-10 | |
Hair clippers | AESCULAP | B00VAQ4KUY (ISIS) | |
Heating pad | Petelevage | 120070 | |
Isofluorane | Piramal healthcare | FR/V/03248850/2011 | |
Ketamine | Imalgene | FR/V/0167433 4/1992 | surgical anesthetic, administered intraperitoneally at a dose of 100mg/kg |
Lactated Ringers solution | Flee-Flex | 1506443 | |
Lamina multilabel slide scanner | Perkin Elmer | ||
LAS software | Leica | version 2.7.3 | |
Leica Bond III | Leica Biosystem | 1757 | |
Leukosilk dressing | BSN medical | 72669-01 | |
Lidocaine | Aguettant | N01BB02 | local analgesic, administered subcutaneously at a dose of 0.05 μg/ g |
Manometer | Kern | HDB-5K5 | |
Masson Trichrome Staining kit | Sigma-Aldrich | HT15-1KT | |
Micromesh Biopsy cassettes | Simport | M507 | |
Multiphoton inverted stand Leica SP5 microscope | Leica microsystems | DM500 | Scanner 8000Hz NDD PMT detectors |
Non adhering dressing Adaptic | Systagenix | A6222 | 12.7cm X 22.9 cm |
Ocrygel | Tvm France | ### | |
Paracetamol 300mg | Dolliprane | Liquiz | |
Paraformaldheyde 4% | VWR chemicals | 1169945 | |
Povidone-iodine | MEDA pharma | D08AG02 | diluted to 1:2 |
SKH1-Hrhr mouse | Charles river | 686SKH1-HR | 6-weeks old |
Slides | Thermoscientific | AGAA000080 | |
Surgical adhesive | BSN medical | 9927 | |
Sterile Gauze | Hartmann | 418545/9 | 10 X 10 cm |
Sterile water | Versylene Fresenius | B230521 | |
Surgical drape | Hartmann | 2775161 | |
Ti:Sapphire ChameleonUltra | Coherent | DS 16-02-16 F | 690-1040 nm |
Thermal imaging Camera | Testo | Testo 868 | |
Xylazine (Rompum 2%) | Bayer | FR/V/ 8146715 2/1980 | surgical anesthetic, administered intraperitoneally at a dose of 10 mg/kg |